Syneron seeks buyer for $322m

Shimon Eckhouse
Shimon Eckhouse

Apax Partners is among those interested in the Israeli esthetic medicine company.

Israeli esthetic medicine company Syneron Medical Ltd. (Nasdaq: ELOS) is looking for a buyer. The company has hired Barclays Investment Bank for the task, and Apax Partners is among those interested. Syneron's market cap is $322 million. The company's share price climbed 10% over the past year, but it is still far from the peak it reached more than a decade ago.

It cannot be ruled out that the company will be sold at a price close to $400 million.

The hoped-for acquisition follows the acquisition of two of Syneron's main Israeli competitors, Lumenis and Alma Lasers. Alma Lasers, a private company was sold to China's Fosun Pharma for $240 million, and Lumenis was sold to private equity fund XIO Group for $510 million at a 16% premium on the company's market price at the time.

Return to profitability

Syneron posted $277 million in revenue in 2015 and $215 million in the first nine months of 2016. The company's main problem lies in its profit line. The company formerly made good profits, but posted a $6.4 million loss in 2015, following losses in the preceding years. Syneron made a $1.1 million profit in the first nine months of 2016, with $71 million in revenue in the third quarter, up 15.3%, $24 million of which was accounted for by new products, a 61% increase. Half of the revenue from new products came from a product obtained through the acquisition of Israeli company UltraShape.

Syneron recently obtained approval for its product for treatment of cellulitis, a product regarded as the company's growth engine. Syneron, which has $82 million in cash, is scheduled to publish its annual financial statements in two days. Syneron was founded by Dr. Shimon Eckhouse after he was ousted from Lumenis, which he also founded, by a hostile takeover.

Syneron overtook Lumenis in performance in the 1990s, after which the two companies competed head-to-head while having similar Nasdaq market caps. Lumenis also developed in the direction of the non-esthetic medical market, based on its laser and energy technology. Syneron expanded into other esthetic areas, primarily through acquisitions.

CEO Amit Meridor manages Syneron, while Eckhouse serves as chairman and owns a 7% stake in the company.

Esthetic market no longer Israeli

The medical esthetic market, which has been dominated by Israeli companies since its 1990s boom, is moving into non-Israeli hands (although the Israeli companies are still active). Considerable consolidation has taken place in the field in recent years, with the non-Israeli companies also being acquired or merged - for example Candela, acquired by Syneron itself.

The consolidation process has been spurred by saturation in the core business of esthetic medicine (in hair removal, for example) and intense competition. The past quarter's 51% gross profit margins are nowhere near the margins of 80% or more when the esthetic market began. Non-Israeli competitors have also arisen, such as Cynosure and Lutronic. Younger and smaller companies still remain in Israel, such as EndyMed, Venus Concept, and PerfAction.

Published by Globes [online], Israel Business News - www.globes-online.com - on February 13, 2017

© Copyright of Globes Publisher Itonut (1983) Ltd. 2017

Shimon Eckhouse
Shimon Eckhouse
Itamar Ben-Gvir  credit: Noam Moskowitz, Knesset Spokesperson's Office Otzma Yehudit rejoins government

Itamar Ben-Gvir's party left the government in January in protest against the ceasefire in Gaza. The resumption of fighting has paved its way back.

Wiz founders Yinon Costica, Assaf Rappaport, Ami Luttwak, Roy Reznik credit: Avishag Shaar Yishuv Israel's biggest ever exit: Google buying Wiz for $32b

Google has confirmed that an agreement has been signed for an all-cash deal. Wiz will remain an independent company under Google.

Bezhalel Machlis  credit: Assaf Shilo/Israel Sun Elbit Systems CEO: Our potential in Europe is huge

Bezhalel Machlis was speaking at an investor conference after the company released 2024 results showing revenue up 14.3%.

Gaza Strip, March 17 2025  credit: Reuters/Anadolu IDF resumes assault on Hamas

Extensive aerial attacks were carried out against targets in the Gaza Strip overnight.

Wiz founders Yinon Costica, Assaf Rappaport, Ami Luttwak, Roy Reznik credit: Avishag Shaar Yishuv Google renews attempt to buy Wiz - report

According to "The Wall Street Journal", Google parent company Alphabet is negotiating to buy the Israeli cloud computing security company for $30 billion.

Orit Strook  credit: Marc Israel Sellem/The Jerusalem Post Finance C'ttee approves NIS 300m coalition funds distribution

The money will mainly go to Religious Zionist party minister Orit Strook's Ministry of Settlements and National Missions.

Dangoor Academy  credit: British Embassy in Tel Aviv British Embassy showcases Israeli healthcare startups

The nine startups participated in the Dangoor HealthTech Academy, a program that connects Israeli startups with the UK healthcare system.

NextVision Stabilized Systems  credit: Shlomi Yosef/Tali Bogdanovsky Next Vision shareholders make NIS 230m exit

A British hedge fund has bought a 2.5% stake in the stabilized cameras company.

Energean CEO Mathios Rigas at the Israel Business Conference   credit: Shlomi Yosef Energean's $1b gas fields sale at risk

The sale of the energy company's asset portfolio in Egypt, Italy and Croatia may fall through because of the buyer's difficulties with the Italian regulator.

Kela Technologies founders Jason Manne, Hamutal Meridor, Alon Dror and Omer Bar Ilan  credit:  Yosef Haim Alterman Defense tech co Kela raises $39m

In response to the events of October 7, Kela has developed a platform for rapid integration of commercial technologies into military systems.

Benjamin Netanyahu  credit: ‎Alex Kolomoisky, Yediot Aharonot Firing the Shin Bet chief: The hurdles

Prime Minister Benjamin Netanyahu says he has "lost trust" in Shin Bet head Ronen Bar. Will this be enough to overcome legal challenges to his dismissal?

Emiliano Calemzuk  credit: PR CEO and "investor group" buying out Reshet 13

CEO Emiliano Calemzuk and the other investors will hold 74% of the television channel, while Len Blavatnik’s Access Industries and WBD will remain with 26%.

Inflation  credit: Tali Bogdanovsky Unexpectedly low February CPI reading cuts inflation

While inflation in Israel in the 12 months to the end of February 2025 is lower than forecast, housing prices continue to rise.

Yitzhak Tshuva credit: Gidon Levy and Tali Bogdanovsky Competition Authority allows Delek takeover of Isracard

The Competition Authority is considered the easier of the two regulatory hurdles that the deal must overcome, the other being the Supervisor of Banks.

David Amsalem  credit  Noam Moskowitz, Knesset Spokesperson's Office Rafael to pay state NIS 444m dividend

The minister in charge of the Government Companies Authority, David Amsalem, has approved the payment by the defense company.

Barak MX air defense system  credit: IAI IAI profit jumps 55%

Israel Aerospace Industries posted a net profit of $493 million for 2024, and ended the year with an all-time high orders backlog of $25 billion.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018